Researchers at the University of Florida are developing a new nutritional supplement that promises to treat type 2 diabetes by boosting the absorption of essential fatty acids in foods.
The company, Almond Butter Nutrition, is developing the product as part of a program to develop nutritional supplements for the treatment of diabetes.
“There are currently no approved dietary supplements that contain sufficient amounts of fatty acids to treat diabetes,” the company says on its website.
“This product will allow us to improve the overall health of the population through the absorption and utilization of fatty acid levels.”
The company says it has received funding from the Howard Hughes Medical Institutes, the National Institutes of Health, and the National Heart, Lung, and Blood Institute.
Almond Butter has received approval from the FDA and the American Diabetes Association.
The supplement is a blend of coconut oil and almond extract.
According to the company, the product contains 1,000mg of omega-3s and 1,200mg of polyunsaturated fatty acids.
The product has been tested in the laboratory and in a clinical trial with patients with type 2 Diabetes.
The company is also working with a private diabetes company to develop a formulation that would target patients with Type 2 Diabetes, said Almond Chief Executive Officer and CEO Michael M. Leavitt.
The company has already received approval for the formulation from the Diabetes Action Network, according to the Associated Press.
The FDA has also approved the formulation for sale to other manufacturers, Leavitz said.
“We are proud to partner with the Diabetes Prevention Foundation and the Howard H. Hughes Medical Institute to make Almond a premier supplement for the prevention and treatment of Type 2 diabetes,” Leavitch said.
“Almond has been in development for years and has the ability to address many of the clinical and public health challenges associated with Type 1 diabetes.”
Almonds, which are also known as nut butters, are an ingredient found in many processed foods, including peanut butter, peanut oil, and many packaged foods.
Almonds are considered an essential component in many of these foods, because they are a source of vitamin E, magnesium, and zinc.
A study published in the journal Diabetes Care found that nut butter consumption has been associated with better blood lipid profiles, lower body mass index, and lower levels of risk factors for cardiovascular disease.
The AP reported that Almond’s formulation has been found to be safe and effective.
Leavaitt said that he hopes the company can be able to distribute the supplement to other companies, including other diabetes organizations.
It’s not clear when Almond will begin distributing the product.
Levitt declined to provide any details about how the company will distribute the product, but he said it’s “working very closely with a number of partners to develop the next generation of supplements.”
Source: Wall Street Review
